129
Participants
Start Date
March 31, 2013
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation.
Tables containing: Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation.
Simvastatin 20 mg + Ezetimibe 10 mg and Simvastatin 40 mg + Ezetimibe 10 mg, according to clinical evaluation.
Tables containing: Simvastatin 20 mg + Ezetimibe 10 mg and Simvastatin 40 mg + Ezetimibe 10 mg, according to clinical evaluation.
Centro de Pesquisas em Diabetes e Doenças Endócrino-Metabólicas- UFC, Fortaleza
Centro de Pesquisas Médicas Básica e Clínica, Recife
CCBR Brasil Centro de Pesquisas e Análises Clínicas, Rio de Janeiro
CEPIC Centro Paulista de Investigação Clínica, São Paulo
FGM - Clínica Paulista de Doenças Cardiovasculares, São Paulo
Hospital do Rim e Hipertensão, São Paulo
Universidade Federal de São Paulo, São Paulo
Lead Sponsor
Ache Laboratorios Farmaceuticos S.A.
INDUSTRY